GGrantIndex
← Search

Planning and Evaluation

$36,947P30FY2020CANIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications, trials & patents

Trial NCT02989636Trial NCT02516670Trial NCT02491411Trial NCT02489357Trial NCT02029950Trial NCT01935947Trial NCT01870596Trial NCT01783171Trial NCT01757639Trial NCT01578109Trial NCT01349972Trial NCT01349959Trial NCT01330173Trial NCT01264432Trial NCT01207726Trial NCT01207687Trial NCT01139970Trial NCT01132573Trial NCT01061749Trial NCT00971737Trial NCT00963807Trial NCT00899951Trial NCT00899548Trial NCT00898482Trial NCT00897338Trial NCT00897273Trial NCT00847171Trial NCT00795002Trial NCT00727441Trial NCT00673569Trial NCT00670917Trial NCT00660348Trial NCT00641303Trial NCT00641147Trial NCT00631137Trial NCT00616967Trial NCT00602771Trial NCT00588991Trial NCT00566098Trial NCT00524017Trial NCT00499733Trial NCT00499486Trial NCT00493025Trial NCT00492921Trial NCT00489281Trial NCT00478062Trial NCT00478010Trial NCT00471653Trial NCT00470093Trial NCT00469820Trial NCT00445484Trial NCT00433472Trial NCT00425477Trial NCT00407966Trial NCT00401024Trial NCT00389610Trial NCT00387465Trial NCT00381550Trial NCT00373191Trial NCT00369681Trial NCT00368914Trial NCT00363649Trial NCT00361296Trial NCT00356928Trial NCT00354640Trial NCT00343447Trial NCT00336063Trial NCT00334542Trial NCT00324870Trial NCT00313560Trial NCT00311623Trial NCT00305760Trial NCT00303927Trial NCT00293410Trial NCT00293397Trial NCT00293280Trial NCT00290732Trial NCT00287989Trial NCT00287872Trial NCT00281970Trial NCT00281866Trial NCT00278200Trial NCT00278161Trial NCT00278109Trial NCT00276744Trial NCT00276601Trial NCT00276588Trial NCT00274768Trial NCT00265915Trial NCT00265837Trial NCT00262834Trial NCT00258206Trial NCT00258180Trial NCT00255775Trial NCT00255710Trial NCT00245115Trial NCT00244959Trial NCT00242996Trial NCT00238368Trial NCT00238277

Abstract

ABSTRACT To augment the impact of Sidney Kimmel Comprehensive Cancer Center (SKCCC) research on cancer screening, detection, diagnosis, prevention and treatment in its catchment area and throughout the world, the SKCCC leadership, with the support of expert internal and external advisers, has created a new five-year Strategic Plan. The Plan has been accepted and approved by the Dean of the Medical Faculty/CEO of Johns Hopkins Medicine, President of the Johns Hopkins Hospital and Health System and the Dean of the Bloomberg School of Public Health. The SKCCC Director garners advice on Program planning, resource allocation, identification of new opportunities and launching of new initiatives from several key internal committees, including the: 1) Executive Oversight Committee (EOC), 2) Program Leaders Council, 3) Protocol Review and Monitoring Committee, 4) Safety Monitoring Committee, 5) Laboratory Shared Resources Committee and 6) Clinical Research Operations Committee. The governance of the SKCCC functions with two major values: 1) maximizing the impact of SKCCC resources (people, space and funds) to achieve research goals and 2) creating an efficient, effective, responsive and collegial environment that promotes and fosters collaborative team science. An External Advisory Board (EAB) is composed of national leaders representing major areas of cancer research, administration and advocacy from pre-eminent institutions across the U.S. Over this grant period, the EAB played a critical role in the evaluation of Scientific Programs and the re-engineering of the Programmatic structure at the SKCCC. EAB members have also generously provided individual consultations on their specific areas of expertise. Moving forward, the EAB will critically monitor the output and effectiveness of SKCCC Programs, cores and leadership.

View original record on NIH RePORTER →